Special Issue "Biopharmaceutical Process Development"


A special issue of Bioengineering (ISSN 2306-5354).

Deadline for manuscript submissions: closed (30 September 2014)

Special Issue Editor

Guest Editor
Prof. Dr. Christoph Herwig
Department of Chemical Engineering, Research Area Biochemical Engineering, Vienna University of Technology, Austria
Website: http://institute.tuwien.ac.at/chemical_engineering/bioprocess_engineering
E-Mail: christoph.herwig@tuwien.ac.at
Interests: integrated bioprocess development; monitoring; modeling and control of bioprocesses; data–information–knowledge; scale down models

Special Issue Information

Dear Colleagues,

Process development for the industrial production of biopharmaceutical drug substances is still time consuming. In addition, the process continues to have a high risk to fail at the manufacturing scale, due to high variability of biological origin and of the various input materials.

Not long ago, the regulatory bodies launched the Quality by Design (QbD) initiative, which proposes a systematic, science driven and risk based approach to process development. However, the current interpretation of QbD is mainly data driven, using statistical approaches, identifying correlations (“How” parameters and attributes are correlated), without emphasizing “Why”. Therefore, QbD is perceived to be laborious and does not reach the full potential of its intention.

The current special issue emphasizes scientific and risk based methods to accelerate bioprocess development while allowing a mechanistic approach for process understanding and safe scale up. As a consequence, it is reviving QbD also as a new business opportunity.

We look forward to receiving your contributions to these cutting edge issues.

Prof. Dr. Christoph Herwig
Guest Editor


Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed Open Access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. For the first couple of issues the Article Processing Charge (APC) will be waived for well-prepared manuscripts. English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.

Special Issue Flyer

Please download the special issue flyer here.


  • integrated bioprocess development
  • microbial and mammalian host organisms
  • biopharmaceutical drugs
  • upstream and downstream processing
  • scale up, scale down models
  • multivariate explorative analysis
  • mechanistic modeling
  • hybrid modeling
  • bioprocess control

Published Papers (3 papers)

Download All Papers
Sort by:
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-3
p. 213-230
by , ,  and
Bioengineering 2014, 1(4), 213-230; doi:10.3390/bioengineering1040213
Received: 31 July 2014; in revised form: 18 September 2014 / Accepted: 17 October 2014 / Published: 24 October 2014
Show/Hide Abstract | PDF Full-text (939 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biopharmaceutical Process Development)
p. 188-212
by ,  and
Bioengineering 2014, 1(4), 188-212; doi:10.3390/bioengineering1040188
Received: 1 August 2014; in revised form: 12 September 2014 / Accepted: 29 September 2014 / Published: 1 October 2014
Show/Hide Abstract | PDF Full-text (538 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biopharmaceutical Process Development)
p. 154-187
by , ,  and
Bioengineering 2014, 1(4), 154-187; doi:10.3390/bioengineering1040154
Received: 29 July 2014; in revised form: 9 September 2014 / Accepted: 22 September 2014 / Published: 29 September 2014
Show/Hide Abstract | PDF Full-text (1637 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biopharmaceutical Process Development)
Select/unselect all
Displaying article 1-3
Select articles Export citation of selected articles as:

Last update: 21 July 2014

Bioengineering EISSN 2306-5354 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert